about
Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesNaloxonazine, an Amastigote-Specific Compound, Affects Leishmania Parasites through Modulation of Host-Encoded FunctionsComplex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosisEpigenetic Regulation of Matrix Metalloproteinase-1 and -3 Expression in Mycobacterium tuberculosis Infection.Update in Mycobacterium tuberculosis lung disease 2014.Ohmyungsamycins promote antimicrobial responses through autophagy activation via AMP-activated protein kinase pathway.Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious DiseasesHost sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis.Autophagy in Mycobacterium tuberculosis and HIV infectionsSignificant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune ResponseNew Role for FDA-Approved Drugs in Combating Antibiotic-Resistant BacteriaSuppress for Success: A JAK Inhibitor for Adjunct Therapy of TuberculosisThe COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection.Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine EfficacyToxoplasma gondii GRA7-Targeted ASC and PLD1 Promote Antibacterial Host Defense via PKCαRoflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis.Targeting Batf2 for infectious diseases and cancer.The pregnane X receptor in tuberculosis therapeutics.Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model.Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a reviewFine-tuning of macrophage activation using synthetic rocaglate derivatives.Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization PredictionsPharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis.Statin adjunctive therapy shortens the duration of TB treatment in mice.The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis.Stringent Response Factors PPX1 and PPK2 Play an Important Role in Mycobacterium tuberculosis Metabolism, Biofilm Formation, and Sensitivity to Isoniazid In Vivo.Targeting Innate-Like T Cells in Tuberculosis.M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.Personalized medicine for patients with MDR-TB.Interleukin-37: a new molecular target for host-directed therapy of tuberculosis.Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis.A potential target gene for the host-directed therapy of mycobacterial infection in murine macrophages.Autophagy as a target for therapeutic uses of multifunctional peptides.The long and winding road to inhaled TB therapy: not only the bug's fault.Mortality in Severe Human Immunodeficiency Virus-Tuberculosis Associates With Innate Immune Activation and Dysfunction of Monocytes.Factors associated with pulmonary impairment in HIV-infected South African adults.Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.Regulation of phagocyte triglyceride by a STAT-ATG2 pathway controls mycobacterial infection.
P2860
Q28081001-9AC160AE-A416-46BE-9521-81C400C9904FQ28468455-ADEDCA2D-6843-4332-B953-2917D4A68B79Q28817395-C47E2DE4-0F99-434D-98B5-415835B01772Q30354642-D2147FD5-1513-4B63-8C68-2F5E03C77142Q33735642-20E0C0DF-8E33-49EA-8E7D-FDE1344162E5Q33794131-4A44460E-E0F1-4649-81BF-BF22D59D199EQ33849778-7207D6F1-01A1-4790-972E-774308DFBBE0Q33894427-1F27ABB7-1AF4-4DA9-B0EF-DD749FF0C630Q35672114-A8F9B965-5328-435A-82B9-CB65B471C4D7Q35783492-DD64F334-03BF-4FA1-AECD-1B9AED392D2AQ35922094-E992B72E-B58F-4DD0-B6C7-E5F6311A2C35Q35986316-13C043CE-5687-4E7E-96DE-317434932F3AQ36038676-4F3E695A-8B15-4C14-BF72-749EF3F102ECQ36173327-66A30AA6-AA96-4AEE-B189-9272A24809EDQ36219941-5D287299-532A-4B73-9AB4-DA238EEEBF43Q36261479-2BC23E34-425A-4739-957D-B017E05BA2C0Q36290586-313C63A9-7BDE-4240-AB12-8D1BE7461594Q36413539-445BB662-8F70-4C81-A91A-CD3EC09576B2Q36451492-07142612-3425-4646-BA26-DF5DDE71B624Q36645097-BA13A302-B6EF-446C-B339-360F0A8C8914Q36653997-67DAF7DE-B1BC-43AD-AAB8-C582B456EE9FQ36806462-29A3FF91-A589-49E8-A6CA-F4984AD633DBQ36888550-B0C7B0B5-F5CA-4FB7-A256-9F1D83D90F03Q37014319-C4ADE077-2783-4536-B57C-A9214F9E874BQ37223747-5EE0A7E7-F3F1-4AF2-84D1-FFFB784C27DEQ37277346-E5330763-5621-45DD-9AD8-2963CD7FC4B7Q37358614-04B098AB-A85E-46EF-8AAE-7EC04DDAB379Q37522519-02D7296C-42D1-46DB-9DE1-A73A04B3AC05Q37609295-302564B5-416B-44BD-B99E-080B8685B518Q38613635-B562A9DC-2814-464B-9713-87BECB89DF35Q38617675-0C75C1BD-A292-4DBF-B761-2DC971FA1085Q38686666-81760C21-CC4C-4F91-99FD-C192B3202FDCQ38746059-9BDC8235-AD63-406D-87B3-FE978F6FEECFQ38757143-622CDFA3-3228-40C3-B51B-53D0C7D72D36Q38770314-3DEC00DF-3416-4D67-B3B8-1D8DEF8C4871Q38782463-F66331E0-66D9-4CD1-A523-52879A490B9FQ39101295-C535969D-F18D-4991-B3A6-B77739B192FEQ40043422-1D1159B8-766A-44C1-9AD5-1E185A41EED7Q40124133-3D3D585F-C3F7-4EA1-9FDF-6FCE1515F0A1Q40307073-27CF1DDF-A218-4BF0-9F87-6E70704FB9C6
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Advancing host-directed therapy for tuberculosis.
@ast
Advancing host-directed therapy for tuberculosis.
@en
Advancing host-directed therapy for tuberculosis.
@nl
type
label
Advancing host-directed therapy for tuberculosis.
@ast
Advancing host-directed therapy for tuberculosis.
@en
Advancing host-directed therapy for tuberculosis.
@nl
prefLabel
Advancing host-directed therapy for tuberculosis.
@ast
Advancing host-directed therapy for tuberculosis.
@en
Advancing host-directed therapy for tuberculosis.
@nl
P2860
P356
P1476
Advancing host-directed therapy for tuberculosis.
@en
P2093
Richard Hafner
Robert S Wallis
P2860
P304
P356
10.1038/NRI3813
P577
2015-03-13T00:00:00Z